98 results on '"Drosten, Christian"'
Search Results
2. SARS-CoV-2 rapid antigen test sensitivity and viral load in newly symptomatic hospital employees in Berlin, Germany, December, 2020 to February, 2022: an observational study
3. SARS-CoV-2 BA.2.86 enters lung cells and evades neutralizing antibodies with high efficiency
4. Distinct phenotype of SARS-CoV-2 Omicron BA.1 in human primary cells but no increased host range in cell lines of putative mammalian reservoir species
5. Whole genome sequencing reveals insights into hepatitis E virus genome diversity, and virus compartmentalization in chronic hepatitis E
6. Primary series COVID-19 vaccine effectiveness among healthcare workers in Albania, February–December 2021
7. Endogenous IFITMs boost SARS-Coronavirus 1 and 2 replication while overexpression inhibits infection by relocalizing ACE2
8. Corrigendum to ’Replication of human coronaviruses SARS-CoV, HCoV-NL63 and HCoV-229E is inhibited by the drug FK506’ Virus Research (2012) 165/1 [112-117]
9. Importance of external quality assessment for SARS-CoV-2 antigen detection during the COVID-19 pandemic
10. Access and benefit-sharing by the European Virus Archive in response to COVID-19
11. Accuracy and ease-of-use of seven point-of-care SARS-CoV-2 antigen-detecting tests: A multi-centre clinical evaluation
12. Accuracy and ease-of-use of seven point-of-care SARS-CoV-2 antigen-detecting tests: A multi-centre clinical evaluation
13. SARS-CoV-2 Rapid Antigen Test Sensitivity and Viral Load in Freshly Symptomatic Hospital Employees, December 2020 to February 2022
14. Endogenous IFITMs Boost SARS-Coronavirus 1 and 2 Replication While Overexpression Prevents Infection by Reducing Cell Surface Levels of ACE2
15. Impact of dexamethasone on SARS-CoV-2 concentration kinetics and antibody response in hospitalized COVID-19 patients: results from a prospective observational study
16. SARS-CoV-2 infection triggers profibrotic macrophage responses and lung fibrosis
17. Safety, reactogenicity, and immunogenicity of homologous and heterologous prime-boost immunisation with ChAdOx1 nCoV-19 and BNT162b2: a prospective cohort study
18. Long-term immunogenicity of BNT162b2 vaccination in older people and younger health-care workers
19. Increased risk of severe clinical course of COVID-19 in carriers of HLA-C*04:01
20. Impact of dexamethasone on SARS-CoV-2 concentration kinetics and antibody response in hospitalized COVID-19 patients: results from a prospective observational study
21. A time-resolved proteomic and prognostic map of COVID-19
22. Comparison of seven commercial SARS-CoV-2 rapid point-of-care antigen tests: a single-centre laboratory evaluation study
23. Science, not speculation, is essential to determine how SARS-CoV-2 reached humans
24. Interferon antagonism by SARS-CoV-2: a functional study using reverse genetics
25. Impaired performance of SARS-CoV-2 antigen-detecting rapid diagnostic tests at elevated and low temperatures
26. Potential benefit of convalescent plasma transfusions in immunocompromised patients with COVID-19
27. Transcriptomic profiling of SARS-CoV-2 infected human cell lines identifies HSP90 as target for COVID-19 therapy
28. Evaluation of a SARS-CoV-2 rapid antigen test: Potential to help reduce community spread?
29. SARS-CoV-2 Antibodies in Children: A One-Year Seroprevalence Study From June 2020 to May 2021 in Germany
30. The Global Response to the COVID-19 Pandemic
31. A Therapeutic Non-self-reactive SARS-CoV-2 Antibody Protects from Lung Pathology in a COVID-19 Hamster Model
32. Inhibition of SARS–CoV-2 by type I and type III interferons
33. Severe COVID-19 Is Marked by a Dysregulated Myeloid Cell Compartment
34. Investigation of a COVID-19 outbreak in Germany resulting from a single travel-associated primary case: a case series
35. Ultra-High-Throughput Clinical Proteomics Reveals Classifiers of COVID-19 Infection
36. Stability and neutralising capacity of SARS-CoV-2-specific antibodies in convalescent plasma
37. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
38. Is Africa prepared for tackling the COVID-19 (SARS-CoV-2) epidemic. Lessons from past outbreaks, ongoing pan-African public health efforts, and implications for the future
39. Statement in support of the scientists, public health professionals, and medical professionals of China combatting COVID-19
40. Sero-prevalence, cross-species infection and serological determinants of prevalence of Bovine Coronavirus in Cattle, Sheep and Goats in Ghana
41. The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health — The latest 2019 novel coronavirus outbreak in Wuhan, China
42. A Sars-Cov-2 Neutralizing Antibody Protects from Lung Pathology in a Covid-19 Hamster Model
43. Human Lungs Show Limited Permissiveness for SARS-CoV-2 Due to Scarce ACE2 Levels But Strong Virus-Induced Immune Activation in Alveolar Macrophages
44. Outbreak of COVID-19 in Germany Resulting from a Single Travel-Associated Primary Case
45. The Middle East Respiratory Syndrome (MERS)
46. Enzootic patterns of Middle East respiratory syndrome coronavirus in imported African and local Arabian dromedary camels: a prospective genomic study
47. Virus- and Interferon Alpha-Induced Transcriptomes of Cells from the Microbat Myotis daubentonii
48. Huge diversity of phleboviruses in ticks from Strandja Nature Park, Bulgaria
49. The difficulties in obtaining reliable Zika virus diagnostics
50. Corrigendum to “Phylogenetic analysis of a newfound bat-borne hantavirus supports a Laurasiatherian host association for ancestral mammalian hantaviruses” [Infect. Genet. Evol. 41 (2016) 113–119]
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.